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in  this  series  focus  on  4 main  topics:  the  epidermal  barrier, 
autoimmune skin disease, epithelial viral infection, and the rela-
tionship between the skin and the central nervous system.

























Schematic illustration of several key elements of the skin. As indicated, the skin is divided into 2 main compartments, epidermal (tan) and dermal 
(pink), separated by a basement membrane (blue). The epidermis serves as the protective barrier, due to the differentiation of proliferative epithe-
lial cells in the basal layer to the terminally differentiated cells in the stratum corneum. The sites and development of HPV infection are indicated 
at far left: the primary infection occurs in the basal layer, and mature virion sheds in the stratum corneum. Merkel cells are located within the basal 
layer of the epidermis (purple) and are associated with sensory nerve endings (brown). Two types of cell junctions critical for the integrity of the skin 
are highlighted here. Desmosomes (upper right inset) form cell-cell junctions, in which cadherins (pink and green), such as desmogleins 1 and 3, 
are the extracellular bridges and the autoantigens in different forms of pemphigus. Hemidesmosomes (lower right inset) tether the cells to the 
basement membrane and are composed of a number of proteins, 2 of which — BP230 and BP180 (also known as type XVII collagen) — are auto-
antigens in BP. Disruption of these interactions results in loss of adhesion of the cells to one another or to the underlying basement membrane.
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A “multiple hit” model for the pathogenesis  


















The pathognomonic  blisters  of  pemphigus  arise  from  the 
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Cell-cell interactions in bone marrow. HSCs, the precursors of osteoclasts, reside in a stem cell niche provided by osteoblasts, which, together 
with stromal cells, derive from mesenchymal stem cells. Bone degradation (arrows) results in release of matrix-associated growth factors, 
which stimulate mesenchymal cells and thus bone formation. This “coupling” is an essential consequence of osteoclast activity (98). Addition-
ally, matrix-derived factors stimulate cancer cell proliferation in the so-called “vicious cycle.” Finally, cancer cells release cytokines that target 
mesenchymal cells and thus activate bone resorption.
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and  growth  factors  that,  by  feedback mechanisms,  increase 
growth and/or survival of cancer cells. This loop has been termed 
“the vicious cycle” (Figure 2) (51). Multiple myeloma uses a dif-


































Mechanism of osteoclastic bone resorption. The osteoclast 
adheres to bone via binding of RGD-containing proteins 
(green triangle) to the integrin αvβ3, initiating signals that 
lead to insertion into the plasma membrane of lysosomal 
vesicles that contain cathepsin K (Ctsk). Consequently, the 
cells generate a ruffled border above the resorption lacuna, 
into which is secreted hydrochloric acid and acidic proteases 
such as cathepsin K. The acid is generated by the combined 
actions of a vacuolar H+ ATPase (red arrow), its coupled 
Cl– channel (pink box), and a basolateral chloride–bicar-
bonate exchanger. Carbonic anhydrase converts CO2 and 
H2O into H+ and HCO3–. Solubilized mineral components 
are released when the cell migrates; organic degradation 
products are partially released similarly and partially trans-
cytosed to the basolateral surface for release.
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ratio  is  sufficient  in  itself  to explain the clinical  findings of 
Figure 4
Role of cytokines, hormones, steroids, and prostaglandins in osteoclast formation. Under the influence of other cytokines (not shown), an HSC 
commits to the myeloid lineage, expresses the M-CSF receptor colony-stimulating factor receptor 1 (c-Fms) and then, driven by M-CSF/c-Fms 
signaling and the RANKL receptor RANK, differentiates into an osteoclast. Mesenchymal cells in the marrow respond to a range of hormonal and 
cytokine stimuli, secreting a mixture of pro- and antiosteoclastogenic proteins, the latter primarily being OPG. Glucocorticoids (GCs) suppress 
bone resorption indirectly (by inducing death of osteoblasts) but possibly also target osteoclasts and/or their precursors. Estrogen (E2) inhibits 
secretion of RANKL and TNF-α by T cells via a complex mechanism (not shown); the sex steroid also inhibits osteoclast function.
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resorption  (ref.  84  and  references  therein). This  conundrum 
highlights again the need to discriminate between in vitro cul-
ture experiments using single cytokines and results in vivo. Many 
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